Overview

A Study to Evaluate Participant Satisfaction With Facial Appearance Overall and the Aesthetic and Psychosocial Impact of Combined Facial Treatment

Status:
Completed

Trial end date:
2020-07-29

Target enrollment:

Participant gender:

Summary

The objective of this study is to quantify the psychological and emotional impact of comprehensive aesthetic treatment with a portfolio of Allergan products by measuring the change in participant's satisfaction with facial appearance from baseline to the final study visit.

Phase:

Phase 4

Details

Lead Sponsor:

Allergan

Treatments:

abobotulinumtoxinA
Botulinum Toxins, Type A
Lidocaine
onabotulinumtoxinA